“The compound SR-17018 is the first biased agonist of the mu opioid receptor that doesn't produce tolerance with Serious use,” states Stahl, a senior workers scientist inside the Bohn lab. “This can be a desirable aspect for opportunity use from the context of Continual, serious pain.” Click on Brief INQUIRY to receive a quote from o